# Let’s go Apple …

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/lets-go-apple/
> **Published:** 2026-03-18T22:44:58-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:05:23-04:00
> **Clinical Summary:** When your patient asks if CBD is FDA approved and you have to explain the difference between clinical evidence and regulatory pathways for the hundredth time today. Via r/weed Further Reading Research DigestPM News Update: March 17, 2026 Cannabis Policy WireSchedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I CED [&hellip;]

---

When your patient asks if CBD is FDA approved and you have to explain the difference between clinical evidence and regulatory pathways for the hundredth time today.

Via [r/weed](https://reddit.com/r/weed/comments/1rvrudi/lets_go_apple/)

Further Reading
Research Digest[PM News Update: March 17, 2026](https://cedclinic.com/texas-hemp-stricter-thc-rules-march-31-2026/)
Cannabis Policy Wire[Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I](https://cedclinic.com/scheduling-novel-synthetic-opioids-schedule-i/)
CED Clinic Blog[A single dose of cannabidiol increases ad libitum energy intake in healthy adults but does not affect postprandial glucose or lipid metabolism.](https://cedclinic.com/cannabidiol-effects-on-appetite/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
